To further confirm the utility of HSPE1 as a non-invasive biomarker for BC diagnosis, we measured the concentration of HSPE1 in a large number of urine specimens from 142 hernia, 126 bladder cancer, 67 hematuria, and 59 urinary tract infection patients by sandwich ELISA. This evidence concerns the gene HSPE1 and urinary bladder carcinoma.